Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesStageZero Life Sciences Ltd

StageZero Life Sciences Ltd

Healthcare Diagnostics & Research
PortfolioPortfolio WatchlistWatchlist
Company price
0.04 CAD 0.00(0%)
Last update at 2025-08-20T13:30:00Z
Market Cap
4.94M

Momentum Score

…

StageZero Life Sciences Ltd., a vertically integrated healthcare company, develops and commercializes proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications in North America and Western Europe. Its proprietary platform technology is Sentinel Principle, which identifies RNA-based biomarkers from whole blood. The company's lead product is Aristotle, a mRNA-based multi-cancer panel test for for the detection of multiple discrete cancers from a single sample of blood. It also offers ColonSentry, a blood test to determine an individual's current risk for having colorectal cancer; Prostate Health Index, a screening test for prostate cancer; BreastSentry, a test to determine a woman's risk for developing breast cancer; and COVID-19 Tests. The company is based in Richmond Hill, Canada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.04
Low
0.04
High
52 Week Price Range
0.04
Low
0.04
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
0.04
Dividend Yield
-
Revenue TTM
2.99M
Revenue Per Share
0.03
Gross Profit TTM
1.18M
Debt / Equity
-0.24
ROE
-168.85%
Net Debt
1.78M
ROCE
122.47%
Diluted EPS TTM
-0.16

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -11.42M -7.48M -6.86M -3.48M -3.94M
Net income -14.71M -6.64M -9.71M -1.05M -2.40M
Selling general administrative 5.91M 6.98M 4.02M 4.18M 3.29M
Selling and marketing expenses 0.75M 1.24M - - -
Gross profit -0.40M 1.18M 0.70M -0.96M -1.08M
Reconciled depreciation 0.44M 0.51M 0.22M 0.30M 0.31M
Ebit -7.75M -8.13M -3.70M -5.11M -4.36M
Ebitda -7.46M -7.62M -3.48M -4.81M -4.04M
Depreciation and amortization 0.29M 0.51M 0.22M 0.30M 0.31M
Operating income -7.75M -8.13M -3.70M -5.11M -4.36M
Other operating expenses 11.63M 13.20M 7.51M 5.28M 4.55M
Interest expense 0.22M 0.20M 0.32M 0.80M 1.13M
Tax provision 0.00M - - - -
Interest income - - - 1.61M 0.89M
Net interest income -0.28M -0.20M -0.66M -0.80M -1.13M
Income tax expense 3.30M -0.85M 2.84M -2.43M -1.54M
Total revenue 3.80M 5.07M 4.15M 0.14M 0.19M
Total operating expenses 7.43M 9.31M 4.05M 4.18M 3.29M
Cost of revenue 4.20M 3.89M 3.46M 1.10M 1.27M
Total other income expense net -3.67M 0.65M -3.16M 1.63M 0.41M
Net income from continuing ops -11.42M -7.48M -6.86M -3.48M -3.94M
Net income applicable to common shares -11.42M -7.48M -6.86M -3.48M -3.69M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 0.70M 10.65M 8.51M 1.96M 2.49M
Other current assets 0.12M 0.12M 0.10M 0.05M 0.09M
Total liab 8.20M 7.88M 9.74M 6.46M 7.32M
Total stockholder equity -7.50M 2.76M -1.23M -4.49M -4.84M
Other current liab 2.91M 3.23M 1.50M 1.58M 1.53M
Common stock 101.39M 100.52M 89.33M 80.28M 77.01M
Capital stock 101.39M 100.52M 89.33M 80.28M 77.01M
Retained earnings -123.04M -111.62M -104.14M -97.28M -93.60M
Other liab - 2.36M 3.19M 1.06M 0.49M
Good will 0.00M 7.36M - - 1.04M
Other assets 0.00M 0.03M 0.03M 0.69M 0.03M
Cash 0.02M 1.72M 6.60M 0.07M 0.11M
Total current liabilities 7.03M 4.74M 5.59M 4.22M 5.52M
Current deferred revenue 0.07M 0.20M 0.22M 1.49M 0.05M
Net debt 1.78M -0.37M -3.03M 2.39M 3.12M
Short term debt 1.22M 0.58M 2.60M 1.29M 1.90M
Short long term debt 1.03M 0.36M 2.42M 1.13M 1.90M
Short long term debt total 1.80M 1.36M 3.57M 2.46M 3.22M
Other stockholder equity 12.91M 12.56M 12.27M 11.20M 10.46M
Property plant equipment 0.43M 0.87M 1.26M 1.04M 1.07M
Total current assets 0.27M 2.39M 7.22M 0.23M 0.35M
Net tangible assets - -4.60M -1.23M -4.49M -5.51M
Net receivables 0.03M 0.13M 0.17M 0.02M 0.05M
Long term debt 0.58M 0.58M 0.55M 0.57M 0.95M
Inventory 0.10M 0.41M 0.35M 0.09M 0.11M
Accounts payable 2.82M 0.73M 1.25M 1.35M 2.03M
Accumulated other comprehensive income 1.23M 1.31M 1.30M 1.30M 1.30M
Common stock total equity - - 89.33M 80.28M 77.01M
Non currrent assets other -0.00M 0.03M 0.03M 0.69M 0.03M
Non current assets total 0.43M 8.26M 1.29M 1.74M 2.13M
Capital lease obligations 0.19M 0.42M 0.60M 0.75M -
Long term debt total 0.58M 0.78M 0.97M 1.17M 0.95M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments 0.00M -0.02M -0.07M -0.03M -0.00M
Change to liabilities -0.13M -0.42M 0.08M -0.47M 0.28M
Total cashflows from investing activities 0.00M -0.02M -0.07M -0.03M -0.01M
Net borrowings - -0.39M 0.52M 0.65M 2.52M
Total cash from financing activities 1.83M 4.10M 9.66M 4.59M 3.36M
Change to operating activities - 0.07M 0.16M 0.04M 0.08M
Net income -11.42M -7.48M -6.86M -3.48M -3.94M
Change in cash -1.71M -4.87M 6.53M -0.04M 0.07M
Begin period cash flow 1.72M 6.60M 0.07M 0.11M 0.04M
End period cash flow 0.02M 1.72M 6.60M 0.07M 0.11M
Total cash from operating activities -3.53M -8.95M -3.06M -4.59M -3.29M
Issuance of capital stock 1.54M 3.11M 9.55M 3.94M 1.06M
Depreciation 0.44M 0.51M 0.22M 0.30M 0.31M
Other cashflows from investing activities 0.00M 0.13M 0.00M 0.01M -
Dividends paid - - - - 0.00M
Change to inventory 0.31M -0.05M -0.27M 0.02M -0.03M
Change to account receivables 0.10M -0.05M -0.05M 0.02M 0.01M
Sale purchase of stock 1.54M 4.49M 10.21M 3.94M 1.06M
Other cashflows from financing activities 0.60M 1.40M 0.51M 0.99M 2.41M
Change to netincome 3.68M -1.52M 3.24M -1.12M -0.78M
Capital expenditures 0.00M 0.15M 0.07M 0.04M 0.00M
Change in working capital 3.71M -0.46M -0.08M -0.38M 0.34M
Stock based compensation 0.24M 0.39M 0.64M 0.74M 0.43M
Other non cash items 3.50M -1.91M 3.03M -1.77M -0.42M
Free cash flow -3.53M -9.10M -3.14M -4.64M -3.29M

Peer Comparison*

Sector: Healthcare Industry: Diagnostics & Research

Stock Name
Change
(CAD)
Price
(CAD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
SZLS
StageZero Life Sciences Ltd		 -
-%		 0.04 - 3.37 1.70 5.94 2.34 -0.56
EDT
Spectral Med Inc		 0.03
3.16%		 0.98 - 99.01 163.41 52.98 171.77 -7.51

Profile*

StageZero Life Sciences Ltd

StageZero Life Sciences Ltd., a vertically integrated healthcare company, develops and commercializes proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications in North America and Western Europe. Its proprietary platform technology is Sentinel Principle, which identifies RNA-based biomarkers from whole blood. The company's lead product is Aristotle, a mRNA-based multi-cancer panel test for for the detection of multiple discrete cancers from a single sample of blood. It also offers ColonSentry, a blood test to determine an individual's current risk for having colorectal cancer; Prostate Health Index, a screening test for prostate cancer; BreastSentry, a test to determine a woman's risk for developing breast cancer; and COVID-19 Tests. The company is based in Richmond Hill, Canada.

70 East Beaver Creek Road, Richmond Hill, ON, Canada, L4B 3B2

905 209 2030

https://www.stagezerolifesciences.com

40

Name Title Year Born
Mr. James R. Howard-Tripp Exec. Chairman & CEO NA
Prof. Choong-Chin Liew Co-Founder NA
Mr. Warren Whitehead C.M.A., CPA Chief Accountant 1952
Mr. David Suria Sr. Scientist NA
Mr. James R. Howard-Tripp Executive Chairman & CEO NA
Dr. Choong-Chin Liew Ph.D. Co-Founder NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

PRL
CAD 30.34
+14.45%
OMG
CAD 1.70
+13.76%
ARTG
CAD 39.54
+12.59%
DSV
CAD 10.83
+12.58%
TLRY
CAD 4.17
+12.10%
DRUG
CAD 25.95
-30.02%
HUT
CAD 69.16
-22.20%
UCU
CAD 2.04
-16.39%
PHX
CAD 10.70
-15.62%
VET
CAD 15.04
-13.31%

Equity Sectors*

  • Basic Materials

    +4.80%

  • Communication Services

    +2.78%

  • Consumer Cyclical

    +2.82%

  • Consumer Defensive

    +0.74%

  • Energy

    -4.92%

  • Financial Services

    +2.47%

  • Healthcare

    -0.30%

  • Industrials

    -0.38%

  • Real Estate

    +1.75%

  • Technology

    +0.82%

  • Utilities

    +1.29%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…